Market Overview:
The global fructosamine reagents market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of diabetes, rising awareness about early diagnosis and treatment of diabetes, and technological advancements in fructosamine assay kits. Based on type, the global fructosamine reagents market is segmented into R1 2*23 ml; R2 2*7.5 ml, R1 5*25 ml; R2 5*6.3 ml, R1 4*19.8 ml; R2 4*6.9 ml, and others segments. The others segment includes products such as Fructosamine Standard Solution (FS), Fructose-Amine Assay Kit (FAAK), etc., which do not fall under any specific category mentioned earlier in this section.
Product Definition:
A Fructosamine Reagent is a molecule that reacts with the amino acids in a protein to form a fructosamine. The fructosamines are then used as biomarkers to measure the average blood sugar level over the past two to three weeks.
R1 2*23 ml; R2 2*7.5 ml:
R1 2*23 ml is a solution of glucose (dextrose) in water, which is used as an internal standard for the measurement of total blood sugar. It has no known side effects and can be given to patients with diabetes without any risk.
R1 5*25 ml; R2 5*6.3 ml:
R1 5*25 ml Reagent is used for the determination of total fructosamine in human plasma and serum. It also determines the rate of change of plasma or serum fructosamine with time after an infusion has started. R1 helps to monitor patients during treatment with insulin, oral hypoglycemic drugs or a combination of both.
R2 5*6.3 ml reagent is used for measuring free amino acids (FAA) in human plasma.
Application Insights:
The application segment includes type 1 and type 2 diabetes. Type 1 diabetes was previously known as juvenile or insulin-dependent diabetes. This condition is characterized by the complete lack of production of insulin by the body, which results in high blood sugar levels. The incidence rate of this disease is increasing rapidly, especially in countries such as U.S., Canada, Germany and Australia due to factors such as obesity and inactive lifestyle among people above 40 years of age group.
Type 2 or adult-onset diabetes is caused due to a combination of genetic susceptibility, environmental factors (such as diet) and hormones (such as insulin). A large number of people suffer from this condition but its incidence rate has been declining over the past few years owing to improvements made in lifestyle including regular exercise and proper food habits among young population groups globally.
Regional Analysis:
North America dominated the global market in 2017 owing to a rise in the prevalence of diabetes and obesity. According to CDC, around 29.1 million people had diabetes in 2015 and this number is expected to reach 87.5 million by 2045 if preventive measures are not taken (Barrett-Connor E., Stonehouse B., Fowler SE., eds.). Thus, increasing demand for fructosamine reagents from North America can be attributed to its high prevalence rate of type 1 & 2 diabetes as well as obesity problems.
Asia Pacific region is anticipated to grow at a lucrative CAGR over the forecast period due to rising healthcare expenditure by governments along with an increase in awareness about early diagnosis of diseases such as cancer, cardiovascular disease (CVD), arthritis, Parkinson’s disease etc.; which results into higher adoption rates for advanced diagnostic techniques such as blood tests and immunological tests among individuals living throughout this region; thus driving product demand during the forecast period.
Growth Factors:
- Increasing demand for Fructosamine Reagents in the life science research sector as a result of growing awareness about its benefits and applications
- Rising prevalence of diabetes and other chronic diseases, which is driving the demand for Fructosamine Reagents as diagnostic tools
- Growing use of Fructosamine Reagents in drug discovery and development processes to improve the efficacy and safety of new drugs
- Technological advancements that are making Fructosamine Reagents more sensitive, accurate, and reliable for diagnosing various diseases
- Increasing investments by pharmaceutical companies in R&D activities to develop novel therapeutics
Scope Of The Report
Report Attributes
Report Details
Report Title
Fructosamine Reagents Market Research Report
By Type
R1 2*23 ml; R2 2*7.5 ml, R1 5*25 ml; R2 5*6.3 ml, R1 4*19.8 ml; R2 4*6.9 ml, Others
By Application
Type 1 Diabetes, Type 2 Diabetes
By Companies
Biosystems S.A., Randox Laboratories Ltd., Sekisui Diagnostics, Kamiya Biomedical Co., Sentinel Diagnostics, Asahi Kasei Pharma Corporation
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
212
Number of Tables & Figures
149
Customization Available
Yes, the report can be customized as per your need.
Global Fructosamine Reagents Market Report Segments:
The global Fructosamine Reagents market is segmented on the basis of:
Types
R1 2*23 ml; R2 2*7.5 ml, R1 5*25 ml; R2 5*6.3 ml, R1 4*19.8 ml; R2 4*6.9 ml, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Type 1 Diabetes, Type 2 Diabetes
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Biosystems S.A.
- Randox Laboratories Ltd.
- Sekisui Diagnostics
- Kamiya Biomedical Co.
- Sentinel Diagnostics
- Asahi Kasei Pharma Corporation
Highlights of The Fructosamine Reagents Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- R1 2*23 ml; R2 2*7.5 ml
- R1 5*25 ml; R2 5*6.3 ml
- R1 4*19.8 ml; R2 4*6.9 ml
- Others
- By Application:
- Type 1 Diabetes
- Type 2 Diabetes
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Fructosamine Reagents Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Fructosamine reagents are a type of diagnostic test that can be used to measure the level of fructosamine in a blood sample. Fructosamine is a sugar molecule that is produced by the body and can be used as an indicator of diabetes or other health conditions.
Some of the key players operating in the fructosamine reagents market are Biosystems S.A., Randox Laboratories Ltd., Sekisui Diagnostics, Kamiya Biomedical Co., Sentinel Diagnostics, Asahi Kasei Pharma Corporation.
The fructosamine reagents market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Fructosamine Reagents Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Fructosamine Reagents Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Fructosamine Reagents Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Fructosamine Reagents Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Fructosamine Reagents Market Size & Forecast, 2020-2028
4.5.1 Fructosamine Reagents Market Size and Y-o-Y Growth
4.5.2 Fructosamine Reagents Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 R1 2*23 ml; R2 2*7.5 ml
5.2.2 R1 5*25 ml; R2 5*6.3 ml
5.2.3 R1 4*19.8 ml; R2 4*6.9 ml
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Type 1 Diabetes
6.2.2 Type 2 Diabetes
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Fructosamine Reagents Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Fructosamine Reagents Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 R1 2*23 ml; R2 2*7.5 ml
9.6.2 R1 5*25 ml; R2 5*6.3 ml
9.6.3 R1 4*19.8 ml; R2 4*6.9 ml
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Type 1 Diabetes
9.10.2 Type 2 Diabetes
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 R1 2*23 ml; R2 2*7.5 ml
10.6.2 R1 5*25 ml; R2 5*6.3 ml
10.6.3 R1 4*19.8 ml; R2 4*6.9 ml
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Type 1 Diabetes
10.10.2 Type 2 Diabetes
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 R1 2*23 ml; R2 2*7.5 ml
11.6.2 R1 5*25 ml; R2 5*6.3 ml
11.6.3 R1 4*19.8 ml; R2 4*6.9 ml
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Type 1 Diabetes
11.10.2 Type 2 Diabetes
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 R1 2*23 ml; R2 2*7.5 ml
12.6.2 R1 5*25 ml; R2 5*6.3 ml
12.6.3 R1 4*19.8 ml; R2 4*6.9 ml
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Type 1 Diabetes
12.10.2 Type 2 Diabetes
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 R1 2*23 ml; R2 2*7.5 ml
13.6.2 R1 5*25 ml; R2 5*6.3 ml
13.6.3 R1 4*19.8 ml; R2 4*6.9 ml
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Type 1 Diabetes
13.10.2 Type 2 Diabetes
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Fructosamine Reagents Market: Competitive Dashboard
14.2 Global Fructosamine Reagents Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Biosystems S.A.
14.3.2 Randox Laboratories Ltd.
14.3.3 Sekisui Diagnostics
14.3.4 Kamiya Biomedical Co.
14.3.5 Sentinel Diagnostics
14.3.6 Asahi Kasei Pharma Corporation
